Diabetes
Conditions
Keywords
Diabetes, Self-management, Adherence, Social determinants of health, Social risk factors
Brief summary
This study will refine and test the effectiveness of CareAvenue, an automated e-health tool that informs and activates patients with uncontrolled diabetes to take steps in accessing resources and engaging in self-care. Our central hypothesis is that activating patients with uncontrolled diabetes and linking them to resources to address financial burden and unmet social risk factors will improve both intermediate outcomes and measures of disease control above and beyond existing services, especially for high need patients.
Interventions
CareAvenue is an e-health tool providing information about diabetes management and low-cost resources. Participants in this group have access to CareAvenue and receive a weekly automated phone call and text messages related to CareAvenue and its resources as well as diabetes management.
The Guest Assistance Program (GAP) is a resource, which provides assistance with medical and non-medical needs and resources to patients receiving medical care at University of Michigan health system. Participants in this group are provided with GAP information and receive text messages related to diabetes management.
Sponsors
Study design
Eligibility
Inclusion criteria
* Be 18-75 years of age * Be diagnosed with type 1 or type 2 diabetes with prescribed anti-hyperglycemic medication * Have a most recent hemoglobin A1c(HbA1c) level within the past 6 months of ≥7.5% for individuals ≤70 years and \>8.0% for individuals between 70-75 years in age * Have access to a telephone that can receive and send text messages * Not participating in another diabetes intervention research study
Exclusion criteria
* Significant cognitive impairment precluding individuals from completing the study as evidenced by ability to complete study intake procedures.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in HbA1c as Measured by an HbA1c Machine | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | HbA1c will be measured at baseline, 6 months, and 12 months using HbA1c machine. HbA1c is a measure of the average level of glucose in blood over the past 3 months measured as a percentage. The change in HbA1c from baseline to 12 months is reported here as the primary outcome. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Cost-Related Non-Adherence (CRN) Behaviors related to diabetes will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at diabetes. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Min value of 0, max value of 18, with higher scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome. |
| Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Cost-Related Non-Adherence (CRN) Behaviors related to other conditions being managed will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at other health conditions being managed. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Mean values were obtained, with min value of 0, max value of 1, with higher mean scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome. |
| Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Systolic blood pressure will be measured at baseline, 6 months, and 12 months using an automated blood pressure machine in millimeters of mercury (e.g., 120 mm Hg). The change in systolic blood pressure from baseline to 12 months is reported here as secondary outcome. |
| Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 20 items adapted from the Accountable Health Communities Health-Related Social Needs Screening Tool, the Health Leads Social Needs Screening Toolkit, and the Kaiser Permanente Your Current Life Situation Questionnaire. The item values are binary (yes/no). Higher number of yes responses indicates higher number of unmet social risk factors/higher need. (Min value of 0, max value of 20). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome. |
| Change in Unmet Social Risk Factors as Measured by Participant Questionnaire | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 3 items from the Accountable Health Communities Health-Related Social Needs Screening Tool and 1 item adapted from the National Health Interview Survey. The items each have three response options, in which a positive response indicates an unmet social risk factor. Higher scores indicate more unmet social risk factors (min value of 0; max value of 8). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome. |
| Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) | Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported) | Perceived Financial Burden will be measured at baseline, 6 months, and 12 months by the 11-item measure Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) that were measured on a 5-point scale (0: not at all - 4: very much). The score includes reverse-coding 6-items, summing all items, multiplying sum by 11 and dividing the total by number of items answered. Lower scores indicate higher perceptions of financial burden. (Min value of 0, max value of 44) The change in perceived financial burden (COST measure) from baseline to 12 months is reported here as secondary outcome. |
Countries
United States
Participant flow
Pre-assignment details
After screening eligible and consenting to participate, 67 participants either later changed their mind and declined to participate prior to starting data collection, were unreachable for baseline collection, or did not complete baseline in order to be randomized.
Participants by arm
| Arm | Count |
|---|---|
| CareAvenue (Intervention) Participants receive access to CareAvenue, an e-health tool, and receive one weekly automated telephone call and 4-5 text messages per week for 52 weeks.
CareAvenue: CareAvenue is an e-health tool providing information about diabetes management and low-cost resources. Participants in this group have access to CareAvenue and receive a weekly automated phone call and text messages related to CareAvenue and its resources as well as diabetes management. | 301 |
| Guest Assistance Program (Control) Participants receive information about the Guest Assistance Program (GAP) and receive 3-4 text messages per week related to diabetes management and resources for 52 weeks.
Guest Assistance Program: The Guest Assistance Program (GAP) is a resource, which provides assistance with medical and non-medical needs and resources to patients receiving medical care at University of Michigan health system. Participants in this group are provided with GAP information and receive text messages related to diabetes management. | 299 |
| Total | 600 |
Baseline characteristics
| Characteristic | CareAvenue (Intervention) | Total | Guest Assistance Program (Control) |
|---|---|---|---|
| Age, Continuous | 52.64 years STANDARD_DEVIATION 13.68 | 53.45 years STANDARD_DEVIATION 1304 | 54.26 years STANDARD_DEVIATION 12.33 |
| Health Insurance Type Medicaid | 45 Participants | 79 Participants | 34 Participants |
| Health Insurance Type Medicare | 19 Participants | 44 Participants | 25 Participants |
| Health Insurance Type Medicare + Medicaid Supplemental | 34 Participants | 64 Participants | 30 Participants |
| Health Insurance Type Medicare + Private Supplemental | 68 Participants | 140 Participants | 72 Participants |
| Health Insurance Type None | 2 Participants | 11 Participants | 9 Participants |
| Health Insurance Type Other | 1 Participants | 2 Participants | 1 Participants |
| Health Insurance Type Private | 132 Participants | 260 Participants | 128 Participants |
| Income as percent of poverty level 100-200% | 52 Participants | 95 Participants | 43 Participants |
| Income as percent of poverty level 201-400% | 131 Participants | 261 Participants | 130 Participants |
| Income as percent of poverty level Greater than 400% | 79 Participants | 164 Participants | 85 Participants |
| Income as percent of poverty level Less than 100% | 35 Participants | 73 Participants | 38 Participants |
| Number of chronic conditions | 4.12 number of chronic conditions STANDARD_DEVIATION 2.31 | 4.15 number of chronic conditions STANDARD_DEVIATION 2.31 | 4.18 number of chronic conditions STANDARD_DEVIATION 2.31 |
| Race/Ethnicity, Customized Race Asian | 9 Participants | 23 Participants | 14 Participants |
| Race/Ethnicity, Customized Race Hispanic | 16 Participants | 31 Participants | 15 Participants |
| Race/Ethnicity, Customized Race Multiple Race | 22 Participants | 42 Participants | 20 Participants |
| Race/Ethnicity, Customized Race Non-Hispanic Black | 43 Participants | 101 Participants | 58 Participants |
| Race/Ethnicity, Customized Race Non-Hispanic White | 204 Participants | 388 Participants | 184 Participants |
| Race/Ethnicity, Customized Race Other | 6 Participants | 13 Participants | 7 Participants |
| Region of Enrollment United States | 301 Participants | 600 Participants | 299 Participants |
| Sex/Gender, Customized Gender Female | 168 Participants | 334 Participants | 166 Participants |
| Sex/Gender, Customized Gender Male | 132 Participants | 264 Participants | 132 Participants |
| Sex/Gender, Customized Gender Other | 1 Participants | 2 Participants | 1 Participants |
| Type of diabetes Type 1 | 61 Participants | 130 Participants | 69 Participants |
| Type of diabetes Type 2 | 240 Participants | 470 Participants | 230 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 2 / 301 | 2 / 299 |
| other Total, other adverse events | 75 / 301 | 86 / 299 |
| serious Total, serious adverse events | 123 / 301 | 125 / 299 |
Outcome results
Change in HbA1c as Measured by an HbA1c Machine
HbA1c will be measured at baseline, 6 months, and 12 months using HbA1c machine. HbA1c is a measure of the average level of glucose in blood over the past 3 months measured as a percentage. The change in HbA1c from baseline to 12 months is reported here as the primary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness, unable to obtain measurement, etc.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in HbA1c as Measured by an HbA1c Machine | 0.07 percentage of average glucose 3 months | Standard Deviation 1.57 |
| Guest Assistance Program (Control) | Change in HbA1c as Measured by an HbA1c Machine | -0.10 percentage of average glucose 3 months | Standard Deviation 1.42 |
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire
Cost-Related Non-Adherence (CRN) Behaviors related to diabetes will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at diabetes. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Min value of 0, max value of 18, with higher scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire | -0.45 score on a scale | Standard Deviation 3.52 |
| Guest Assistance Program (Control) | Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Diabetes as Measured by Participant Questionnaire | -0.91 score on a scale | Standard Deviation 3.62 |
Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire
Cost-Related Non-Adherence (CRN) Behaviors related to other conditions being managed will be measured at baseline, 6 months, and 12 months by 4-items adapted from the Medicare Current Beneficiary Survey and 2 items adapted from the National Health Interview Survey that look at other health conditions being managed. The items are measured with a 4-point Likert scale. Participants answering often or sometimes to any of the items are indicated as exhibiting CRN. Mean values were obtained, with min value of 0, max value of 1, with higher mean scores indicating more cost-related non-adherence behaviors. The change in CRN behaviors from baseline to 12 months is reported here as the secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire | -0.07 score on a scale | Standard Deviation 0.45 |
| Guest Assistance Program (Control) | Change in Cost-Related Non-Adherence Behaviors With Prescribed Treatment Regimens Related to Other Conditions Being Managed as Measured by Participant Questionnaire | -0.06 score on a scale | Standard Deviation 0.48 |
Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT)
Perceived Financial Burden will be measured at baseline, 6 months, and 12 months by the 11-item measure Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) that were measured on a 5-point scale (0: not at all - 4: very much). The score includes reverse-coding 6-items, summing all items, multiplying sum by 11 and dividing the total by number of items answered. Lower scores indicate higher perceptions of financial burden. (Min value of 0, max value of 44) The change in perceived financial burden (COST measure) from baseline to 12 months is reported here as secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) | 2.01 score on a scale | Standard Deviation 7.47 |
| Guest Assistance Program (Control) | Change in Perceived Financial Burden as Measured by the Comprehensive Score for Financial Toxicity (COST) - Functional Assessment of Chronic Illness Therapy (FACIT) | 2.74 score on a scale | Standard Deviation 7.36 |
Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine
Systolic blood pressure will be measured at baseline, 6 months, and 12 months using an automated blood pressure machine in millimeters of mercury (e.g., 120 mm Hg). The change in systolic blood pressure from baseline to 12 months is reported here as secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness, unable to obtain measurement, etc.
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine | -4.00 mmHg | Standard Deviation 18.83 |
| Guest Assistance Program (Control) | Change in Systolic Blood Pressure as Measured an Automated Blood Pressure Machine | -6.00 mmHg | Standard Deviation 19.92 |
Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire
Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 20 items adapted from the Accountable Health Communities Health-Related Social Needs Screening Tool, the Health Leads Social Needs Screening Toolkit, and the Kaiser Permanente Your Current Life Situation Questionnaire. The item values are binary (yes/no). Higher number of yes responses indicates higher number of unmet social risk factors/higher need. (Min value of 0, max value of 20). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire | -1.05 yes responses | Standard Deviation 3.69 |
| Guest Assistance Program (Control) | Change in Unmet Social Risk Factors as Measured by 20 Items in Participant Questionnaire | -1.48 yes responses | Standard Deviation 4.1 |
Change in Unmet Social Risk Factors as Measured by Participant Questionnaire
Change in Unmet Social Risk Factors will be measured at baseline, 6 months, and 12 months by 3 items from the Accountable Health Communities Health-Related Social Needs Screening Tool and 1 item adapted from the National Health Interview Survey. The items each have three response options, in which a positive response indicates an unmet social risk factor. Higher scores indicate more unmet social risk factors (min value of 0; max value of 8). The change in unmet social risk factors from baseline to 12 months is reported here as secondary outcome.
Time frame: Assessed at Baseline, 6 months, 12 months (Change between baseline and 12 months reported)
Population: Change from baseline to 12-month follow-up The overall number of participants analyzed is different from the participant flow module due to missingness
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| CareAvenue (Intervention) | Change in Unmet Social Risk Factors as Measured by Participant Questionnaire | -0.26 units on a scale | Standard Deviation 1.42 |
| Guest Assistance Program (Control) | Change in Unmet Social Risk Factors as Measured by Participant Questionnaire | -0.27 units on a scale | Standard Deviation 1.38 |